Sort   by:  
 Page size 
MetabolomicsMetabolic-engineered probiotic-OMVs as nanovaccine mediating sequential immunomodulation for chronic bone infection immunotherapy

Chronic, drug-resistant bone infection caused by methicillin-resistant Staphylococcus aureus (MRSA) features an immunosuppressive niche enabling persistent infection and impaired bone healing. Specific treatment requires initial antibacterial immune activation against infection, followed by resha...

2026-03-19 | MTBLS14091 | MetaboLights
TranscriptomicsRNA-seq of Xylella fastidiosa OMVs and WCL
Xylella fastidiosa is a Gram-negative plant pathogen responsible for severe diseases in a variety of economically important crops. A critical aspect of its pathogenicity is the production of outer membrane vesicles (OMVs). While some knowledge exists on the molecular cargo of X. fastidiosa (Xf)-OMVs...
ORGANISM(S): Xylella fastidiosa 
2025-05-30 | E-MTAB-14502 | biostudies-arrayexpress
Transcriptomicsshort RNA-Seq of Pseudomonas aeruginosa outer membrane vesicles (OMVs) and whole cells
Characterization of the sRNA content of P. aeruginosa OMVs compared to whole cells. Result: OMVs contain differentially packaged sRNAs. Whole cell PA14 and OMVs from 3 separate preparations.
ORGANISM(S): Pseudomonas aeruginosa PAO1 
2016-05-13 | E-GEOD-71598 | biostudies-arrayexpress
GenomicsDNA-seq of Xylella fastidiosa OMVs and WCL
Xylella fastidiosa is a Gram-negative plant pathogen responsible for severe diseases in a variety of economically important crops. A critical aspect of its pathogenicity is the production of outer membrane vesicles (OMVs). While some knowledge exists on the molecular cargo of X. fastidiosa (Xf)-OMVs...
ORGANISM(S): Xylella fastidiosa 
2025-05-30 | E-MTAB-14493 | biostudies-arrayexpress
ProteomicsThe proteomic change of GES1 infected by Helicobacter pylori OMVs
We investigated the effect of H.pylori OMVs on cellular events by detecting proteomic changes in GES1 cells. GES1 cells cocultured with increasing concentrations of H.pylori OMVs were subjected to quantitative proteomic analyses using label-free methods for relative quantitation.
ORGANISM(S): Homo sapiens (Human) 
2022-02-14 | PXD025259 | Pride
Proteomic  ges1  helicobacter pylori  omvs 
GenomicsRNA sequencing of tumor-associated macrophages sorted from OMVs and IN@OMVs-treated mice
RNA sequencing of tumor-associated macrophages sorted from OMVs and IN@OMVs-treated mice
PRJNA1204305 | ENA
ProteomicsThe proteomic of Helicobacter pylori OMVs
In this study, we purified and characterized two types of H.pylori OMVs (standard strain NCTC11637 and clinical strain Hp-400) and analyzed the proteome using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).
ORGANISM(S): Helicobacter pylori J99 (Campylobacter pylori J99) 
2022-02-14 | PXD025216 | Pride
Omvs Proteomic Helicobacter pylori 
GenomicsDNA-seq of Xylella fastidiosa OMVs and WCL
DNA-seq of Xylella fastidiosa OMVs and WCL
PRJEB80741 | ENA
GenomicsRNA-seq of Xylella fastidiosa OMVs and WCL
RNA-seq of Xylella fastidiosa OMVs and WCL
PRJEB80809 | ENA
TranscriptomicsRNA sequencing of tumor-associated macrophages sorted from OMVs and IN@OMVs-treated mice
To investigate the effects of OMVs and IN@OMVs treatments on mouse tumor-associated macrophages, mouse tumors were harvested after treatment, and CD11b+ F4/80+ labeled cells (TAMs) were sorted by FACS for RNA sequencing.
ORGANISM(S): Mus musculus 
2025-07-23 | GSE285523 | GEO
Sort   by:  
 Page size